Metropolitan Life Insurance Company (MetLife)’s Synopsys SNPS Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio SNPS Stock Details SNPS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-6,152	Closed	-$3.52M	–	1812
2024 Q1	$3.52M	Sell	6,152 -39	-0.6%	-$21.5K	0.15%	120
2023 Q4	$3.19M	Sell	6,191 -105	-2%	-$53.7K	0.15%	122
2023 Q3	$2.89M	Sell	6,296 -341	-5%	-$153K	0.15%	122
2023 Q2	$2.89M	Sell	6,637 -180	-3%	-$72.5K	0.14%	129
2023 Q1	$2.63M	Sell	6,817 -1,668	-20%	-$596K	0.14%	135
2022 Q4	$2.71M	Sell	8,485 -407	-5%	-$127K	0.12%	166
2022 Q3	$2.72M	Sell	8,892 -115	-1%	-$38.9K	0.13%	152
2022 Q2	$2.74M	Sell	9,007 -246	-3%	-$74.2K	0.12%	168
2022 Q1	$3.08M	Sell	9,253 -12,434	-57%	-$3.88M	0.11%	173
2021 Q4	$7.99M	Sell	21,687 -447	-2%	-$151K	0.11%	145
2021 Q3	$6.63M	Sell	22,134 -741	-3%	-$225K	0.1%	163
2021 Q2	$6.31M	Sell	22,875 -2,907	-11%	-$738K	0.09%	177
2021 Q1	$6.39M	Sell	25,782 -1,516	-6%	-$385K	0.1%	166
2020 Q4	$7.08M	Sell	27,298 -886	-3%	-$204K	0.11%	153
2020 Q3	$6.03M	Sell	28,184 -1,037	-4%	-$211K	0.1%	156
2020 Q2	$5.7M	Buy	29,221 +100	+0.3%	+$16.5K	0.1%	160
2020 Q1	$3.75M	Sell	29,121 -416	-1%	-$59.2K	0.08%	214
2019 Q4	$4.11M	Sell	29,537 -339	-1%	-$46.5K	0.07%	252
2019 Q3	$4.1M	Buy	29,876 +6,839	+30%	+$925K	0.07%	242
2019 Q2	$2.96M	Buy	23,037 +1,619	+8%	+$195K	0.05%	333
2019 Q1	$2.47M	Sell	21,418 -729	-3%	-$72.2K	0.04%	378
2018 Q4	$1.87M	Buy	22,147 +184	+0.8%	+$16.3K	0.04%	467
2018 Q3	$2.17M	Sell	21,963 -851	-4%	-$81.1K	0.04%	474
2018 Q2	$1.95M	Sell	22,814 -444	-2%	-$38.7K	0.03%	529
2018 Q1	$1.94M	Sell	23,258 -107	-0.5%	-$9.4K	0.03%	549
2017 Q4	$1.99M	Sell	23,365 -48,016	-67%	-$4.15M	0.03%	549
2017 Q3	$5.75M	Sell	71,381 -1,176	-2%	-$91.2K	0.04%	499
2017 Q2	$5.29M	Sell	72,557 -2,153	-3%	-$158K	0.04%	536
2017 Q1	$5.39M	Sell	74,710 -67,269	-47%	-$4.5M	0.04%	542
2016 Q4	$8.36M	Sell	141,979 -577	-0.4%	-$34.3K	0.06%	304
2016 Q3	$8.46M	Sell	142,556 -700	-0.5%	-$39.7K	0.06%	292
2016 Q2	$7.75M	Buy	143,256 +5,303	+4%	+$266K	0.06%	317
2016 Q1	$6.68M	Buy	137,953 +121	+0.1%	+$5.34K	0.05%	375
2015 Q4	$6.29M	Buy	137,832 +588	+0.4%	+$28.4K	0.05%	391
2015 Q3	$6.34M	Sell	137,244 -462	-0.3%	-$22.7K	0.05%	392
2015 Q2	$6.97M	Buy	137,706 +2,180	+2%	+$106K	0.05%	383
2015 Q1	$6.28M	Buy	135,526 +2,939	+2%	+$132K	0.05%	422
2014 Q4	$5.76M	Buy	132,587 +1,152	+0.9%	+$47.8K	0.04%	464
2014 Q3	$5.22M	Buy	131,435 +1,883	+1%	+$74.7K	0.04%	480
2014 Q2	$5.03M	Buy	129,552 +889	+0.7%	+$33.9K	0.03%	537
2014 Q1	$4.94M	Buy	128,663 +2,187	+2%	+$87.8K	0.03%	544
2013 Q4	$5.13M	Buy	126,476 +513	+0.4%	+$19.2K	0.04%	500
2013 Q3	$4.75M	Buy	125,963 +2,204	+2%	+$81.7K	0.04%	504
2013 Q2	$4.42M	Buy	+123,759	New	+$4.4M	0.04%	496

Other funds holding SNPS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s SNPS Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Synopsys (SNPS) in Q2 2024, closing a stake of 6,152 shares — an estimated $3.52M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in SNPS in Q2 2013 and held it in 44 quarters. The position peaked at $8.46M in Q3 2016. 1,254 funds tracked by Wall St. Rank hold SNPS as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Synopsys position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 6,152 Synopsys shares in Q2 2024, an estimated $3.52M.
Metropolitan Life Insurance Company (MetLife) first reported a position in Synopsys in Q2 2013 and held it in 44 quarters.
Metropolitan Life Insurance Company (MetLife)'s Synopsys position peaked at $8.46M in Q3 2016.
1,254 funds tracked by Wall St. Rank held Synopsys as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.